News Home

Should You Hold Instil Bio Inc (TIL) in Biotechnology Industry?

Tuesday, December 06, 2022 03:47 PM | InvestorsObserver Analysts
Should You Hold Instil Bio Inc (TIL) in Biotechnology Industry?

Instil Bio Inc (TIL) is around the middle of the Biotechnology industry according to InvestorsObserver. TIL received an overall rating of 39, which means that it scores higher than 39 percent of all stocks. Instil Bio Inc also achieved a score of 36 in the Biotechnology industry, putting it above 36 percent of Biotechnology stocks. Biotechnology is ranked 54 out of the 148 industries.

Overall Score - 39
TIL has an Overall Score of 39. Find out what this means to you and get the rest of the rankings on TIL!

What do These Ratings Mean?

Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. InvestorsObserver makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts.
These scores are not only easy to understand, but it is easy to compare stocks to each other. You can find the best stock in an industry, or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.

What's Happening With Instil Bio Inc Stock Today?

Instil Bio Inc (TIL) stock is trading at $1.11 as of 3:46 PM on Tuesday, Dec 6, a decline of -$0.12, or -9.43% from the previous closing price of $1.22. The stock has traded between $1.09 and $1.26 so far today. Volume today is below average. So far 480,045 shares have traded compared to average volume of 899,342 shares. Click Here to get the full Stock Report for Instil Bio Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App